假设 发表于 2025-3-23 11:18:50

Submitted on: 29 August 2017.
Revised on: 07 October 2017.
Accepted on: 20 October 2017.

___________________Australian Prescriber---THERAPEUTIC GUIDELINES LTD

秘传 发表于 2025-3-23 17:11:35

http://reply.papertrans.cn/1/32/3154/3154-12.png

试验 发表于 2025-3-23 19:16:28

http://reply.papertrans.cn/1/32/3154/3154-13.png

大笑 发表于 2025-3-23 22:58:00

Submitted on: 30 October 2003.
Revised on: 23 January 2004.
Accepted on: 02 March 2004.

___________________Australian Prescriber---THERAPEUTIC GUIDELINES LTD

雀斑 发表于 2025-3-24 02:21:31

http://reply.papertrans.cn/1/32/3154/3154-15.png

新义 发表于 2025-3-24 07:53:04

Submitted on: 09 November 2010.
Revised on: 30 November 2010.
Accepted on: 24 December 2010.

___________________Australian Prescriber---THERAPEUTIC GUIDELINES LTD

AMOR 发表于 2025-3-24 11:54:30

http://reply.papertrans.cn/1/32/3154/3154-17.png

languor 发表于 2025-3-24 15:47:39

http://reply.papertrans.cn/1/32/3154/3154-18.png

heterodox 发表于 2025-3-24 19:18:04

Submitted on: 20 December 2021.
Revised on: 24 March 2022.
Accepted on: 21 May 2022.

___________________Australian Prescriber---THERAPEUTIC GUIDELINES LTD

招致 发表于 2025-3-24 23:41:23

Submitted on: 04 November 2015.
Revised on: 30 November 2015.
Accepted on: 08 January 2016.

___________________Australian Prescriber---THERAPEUTIC GUIDELINES LTD
页: 1 [2] 3 4
查看完整版本: ESCI期刊Australian Prescriber 2024/2025影响因子:3.474 (AUST PRESCR) (0312-8008). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging So